Describing Patient With DME, Their Patient Journey and Disease Progression

Completed

Conditions studied: Diabetic Macular Edema

In brief

This study aims to characterize patients with diabetic macular edema (DME), their progression, the treatment received and associate the functional and physiological outcomes related to the treatment.

Key facts

Study ID

NCT05966753

Run by

Boehringer Ingelheim

People needed

221004

Starts

2023-08-03

Expected to finish

2023-12-31

Last updated by the study team

2024-12-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients ≥18 years, with a DME diagnosis in at least one eye, included in the Vestrum database identified during the study period (January 2015 to April 2023)

You may not qualify if…

• Patients without the information of laterality will be excluded.

Where it is running

• CorEvitas HQ — Waltham, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.